The global Clinical Chemistry Market is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 6% during the forecast period between 2024 and 2031. In 2024, the market size stands at an estimated US$10 billion, and it is expected to soar to US$15 billion by 2031. Key factors driving this expansion include the increasing elderly population and a surge in the incidence of chronic disorders, along with the growing adoption of Point of Care Testing Kits (POCT) and fully-automated clinical chemistry systems.
This product will be delivered within 1-3 business days.
Growth Drivers for Clinical Chemistry Market
- Increasing Elderly Population and Rise in Chronic Disorders: The global demographic landscape is witnessing a significant increase in the elderly population, which has brought about a higher prevalence of age-related disorders such as hypertension, diabetes, cardiovascular issues, liver, and kidney problems. The demand for diagnostic and treatment tests is consequently on the rise, boosted by preventive care initiatives, which are expected to drive the clinical chemistry market's growth during the forecast period.
- Adoption of Point of Care Testing Kits (POCT) and Analyzers: Point-of-care testing has emerged as a crucial tool for the early detection, diagnosis, and monitoring of various diseases. The growing adoption of POCT kits and analyzers is a major catalyst in the Clinical Chemistry Market's growth. These technologies empower healthcare providers to diagnose illnesses more efficiently and at an earlier stage.
- Fully-Automated Clinical Chemistry Systems: Healthcare institutions worldwide are increasingly acquiring fully-automated clinical chemistry systems equipped with built-in quality-assurance capabilities. These systems can process multiple samples simultaneously and perform tasks such as tube sampling, cap piercing, and dilution, enhancing the overall efficiency of healthcare diagnostic facilities. The rising adoption of these systems is set to drive the Clinical Chemistry Market's expansion throughout the forecast period.
Restraints in the Clinical Chemistry Market
High Capital Investments and Lack of Skilled Professionals: One of the primary constraints on the global clinical chemistry market is the substantial capital investment required to acquire clinical chemistry analyzers. Smaller laboratories and independent practitioners often struggle to afford these analyzers due to their high cost. Additionally, a shortage of skilled professionals, including lab technicians and pathologists, both in developed and emerging nations, poses a significant challenge to market growth.Impact of Covid-19 Pandemic
Decrease in Revenue Due to Drop in Testing Frequency: The COVID-19 pandemic had a notable impact on the Clinical Chemistry Market, with lockdowns leading to a decrease in the frequency of medical testing as patients rescheduled their visits. However, with the relaxation of restrictions in 2021, testing rates are gradually returning to normal. Furthermore, the pandemic has stimulated demand for more precise and accessible testing kits, with major market players developing quick COVID-19 tests to offset the pandemic's impact.Competitive Analysis
The global clinical chemistry market features a limited number of key players who are strategically focusing on growth through mergers and acquisitions to remain competitive in the industry. These companies are making informed decisions regarding both organic and inorganic expansion to broaden their product portfolios and increase market share.Key Companies Profiled
- Danaher Corporation
- Abbott
- F. Hoffmann-La Roche Ltd
- Siemens AG
- Thermo Fisher Scientific Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Cardinal Health, Inc.
- Mindray Medical International Limited
- Hitachi, Ltd.
- Hologic Inc.
- Others
Clinical Chemistry Market Segmentation
Clinical Chemistry Market by Product Type
- Clinical Chemistry Analysers
- Poc Test Kits
- Clinical Chemistry Reagents
Clinical Chemistry Market by End User
- Hospital
- Pathology Laboratories
- Clinics
- Outpatient Centres
- Maternity Centres
Clinical Chemistry Market by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Clinical Chemistry Market Outlook, 2018 - 2031
4. North America Clinical Chemistry Market Outlook, 2018 - 2031
5. Europe Clinical Chemistry Market Outlook, 2018 - 2031
6. Asia Pacific Clinical Chemistry Market Outlook, 2018 - 2031
7. Latin America Clinical Chemistry Market Outlook, 2018 - 2031
8. Middle East & Africa Clinical Chemistry Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Danaher corporation
- Abbott
- F.Hoffmann-La Roche Ltd
- Siemens AG
- Thermo Fisher Scientific Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Cardinal Health, Inc.
- Mindray Medical International Limited
- Hitachi, Ltd.
- Hologic Inc.
Methodology
LOADING...